In Regard to Zietman et al.
1. Perrier L, Morelle M, Pommier P, et al. Cost analysis of complex radiation therapy for patients with head and neck cancer. Int J Radiat Oncol Biol Phys 2016;95:654 662. 2. Fodor A, Di Muzio NG. In Regard to Perrier et al. Int J Radiat Oncol Biol Phys 2016;96:1124. 3. Defourny N, Perrier L, Dunscombe P, et al. The cost of radiotherapy: What do we know? A systematic search of the literature between 1981 and 2015. Value Health 2015;18:A445. 4. Geifman N, Butte AJ. Do cancer clinical trial populations truly represent cancer patients? A comparison of open clinical trials to the cancer genome atlas. Pac Symp Biocomput 2016;21:309 320. 5. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000;342:1887 1892. 6. Servagi Vernat S, Ali D, Puyraveau M, et al. Is IMAT the ultimate evolution of conformal radiotherapy? Dosimetric comparison of helical tomotherapy and volumetric modulated arc therapy for oropharyngeal cancer in a planning study. Phys Med 2014;30:280 285. 7. Servagi Vernat S, Ali D,Messina C, et al. Intensitymodulated arc therapy in bilaterally irradiated head and neck cancer: A comparative and prospective multicenter planning study. Cancer Invest 2014;32:159 167. 8. Johnson ML, Crown W, Martin BC, et al. Good research practices for comparative effectiveness research: Analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: The ISPOR Good Research Practices for Retrospective Database Analysis Task Force ReportdPart III. Value Health 2009;12:1062 1073. 9. The UNICANCER Group. Organisation. Available at: www.unicancer. fr/en/unicancer group/organisation. Accessed September 15, 2016.
International journal of radiation oncology, biology, physics